Suzanne George

Chief, Division of Sarcoma · Mass General Brigham

Credentials: · · ·

History

Count Me In: Partnering with Patients to Define the Clinical and Genomic Landscape of Rare Aggressive Sarcomas in Children and Adults
National Cancer Institute · U2C
PI · $10.2M · Broad Institute, Inc.
2020–2027
Alliance NCORP Research Base
National Cancer Institute · UG1
Contact PI · $11.7M · Alliance Nctn Foundation
2014–2025
Alliance for Clinical Trials in Oncology Operations Center
National Cancer Institute · U10
PI · $112.9M · Alliance Nctn Foundation
2014–2025

PH 2 Pemigatinib in SDH-deficient GIST
Principal investigator · Recruiting · Phase 2
Dana-Farber Cancer Institute
2026–2029
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Principal investigator · Recruiting · Phase 2
Dana-Farber Cancer Institute
2026–2028
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
2019–2024
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
Principal investigator · Completed · Phase 1
Dana-Farber Cancer Institute
2014–2021